AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Bromazepam in South Africa
7 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| BROMAZE 6 | 28/2.6/0216 | Sandoz South Africa (Pty) Ltd | suspended | 21 Jan 2022 |
| BROMAZEPAM 6 KIARA | S/2.6/150 | Kiara Health (Pty) Ltd | active | 1 Jan 1900 |
| BRAZEPAM-3 TABLETS | W/2.6/407 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| BRAZEPAM-6 TABLETS | W/2.6/408 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| LEXOTAN 6 | G/2.6/87 | Pharmaco Distribution (Pty) Ltd | active | 1 Jan 1900 |
| LEXOTAN 3 | G/2.6/86 | Pharmaco Distribution (Pty) Ltd | active | 1 Jan 1900 |
| BROMAZEPAM 3 KIARA | S/2.6/149 | Kiara Health (Pty) Ltd | active | 1 Jan 1900 |
Bromazepam — SAHPRA Registration Details
SAHPRA (South Africa) has 7 registered products containing Bromazepam, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Bromazepam registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.